First Time Loading...

Nevro Corp
NYSE:NVRO

Watchlist Manager
Nevro Corp Logo
Nevro Corp
NYSE:NVRO
Watchlist
Price: 12.0801 USD -3.44% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

NVRO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Nevro Corp. engages in the provision of medical devices. [ Read More ]

The intrinsic value of one NVRO stock under the Base Case scenario is 45.7274 USD. Compared to the current market price of 12.0801 USD, Nevro Corp is Undervalued by 74%.

Key Points:
NVRO Intrinsic Value
Base Case
45.7274 USD
Undervaluation 74%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Nevro Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NVRO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Nevro Corp

Provide an overview of the primary business activities
of Nevro Corp.

What unique competitive advantages
does Nevro Corp hold over its rivals?

What risks and challenges
does Nevro Corp face in the near future?

Has there been any significant insider trading activity
in Nevro Corp recently?

Summarize the latest earnings call
of Nevro Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nevro Corp.

Provide P/S
for Nevro Corp.

Provide P/E
for Nevro Corp.

Provide P/OCF
for Nevro Corp.

Provide P/FCFE
for Nevro Corp.

Provide P/B
for Nevro Corp.

Provide EV/S
for Nevro Corp.

Provide EV/GP
for Nevro Corp.

Provide EV/EBITDA
for Nevro Corp.

Provide EV/EBIT
for Nevro Corp.

Provide EV/OCF
for Nevro Corp.

Provide EV/FCFF
for Nevro Corp.

Provide EV/IC
for Nevro Corp.

Show me price targets
for Nevro Corp made by professional analysts.

What are the Revenue projections
for Nevro Corp?

How accurate were the past Revenue estimates
for Nevro Corp?

What are the Net Income projections
for Nevro Corp?

How accurate were the past Net Income estimates
for Nevro Corp?

What are the EPS projections
for Nevro Corp?

How accurate were the past EPS estimates
for Nevro Corp?

What are the EBIT projections
for Nevro Corp?

How accurate were the past EBIT estimates
for Nevro Corp?

Compare the revenue forecasts
for Nevro Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nevro Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nevro Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nevro Corp compared to its peers.

Compare the P/E ratios
of Nevro Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Nevro Corp with its peers.

Analyze the financial leverage
of Nevro Corp compared to its main competitors.

Show all profitability ratios
for Nevro Corp.

Provide ROE
for Nevro Corp.

Provide ROA
for Nevro Corp.

Provide ROIC
for Nevro Corp.

Provide ROCE
for Nevro Corp.

Provide Gross Margin
for Nevro Corp.

Provide Operating Margin
for Nevro Corp.

Provide Net Margin
for Nevro Corp.

Provide FCF Margin
for Nevro Corp.

Show all solvency ratios
for Nevro Corp.

Provide D/E Ratio
for Nevro Corp.

Provide D/A Ratio
for Nevro Corp.

Provide Interest Coverage Ratio
for Nevro Corp.

Provide Altman Z-Score Ratio
for Nevro Corp.

Provide Quick Ratio
for Nevro Corp.

Provide Current Ratio
for Nevro Corp.

Provide Cash Ratio
for Nevro Corp.

What is the historical Revenue growth
over the last 5 years for Nevro Corp?

What is the historical Net Income growth
over the last 5 years for Nevro Corp?

What is the current Free Cash Flow
of Nevro Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nevro Corp.

Financials

Balance Sheet Decomposition
Nevro Corp

Current Assets 530.9m
Cash & Short-Term Investments 322.7m
Receivables 79.4m
Other Current Assets 128.8m
Non-Current Assets 104.8m
PP&E 33.5m
Intangibles 65.5m
Other Non-Current Assets 5.8m
Current Liabilities 83.4m
Accounts Payable 22.5m
Accrued Liabilities 49.5m
Other Current Liabilities 11.3m
Non-Current Liabilities 259.2m
Long-Term Debt 211.5m
Other Non-Current Liabilities 47.7m
Efficiency

Earnings Waterfall
Nevro Corp

Revenue
425.2m USD
Cost of Revenue
-135.1m USD
Gross Profit
290.1m USD
Operating Expenses
-389.4m USD
Operating Income
-99.3m USD
Other Expenses
7.1m USD
Net Income
-92.2m USD

Free Cash Flow Analysis
Nevro Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NVRO Profitability Score
Profitability Due Diligence

Nevro Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
26/100
Profitability
Score

Nevro Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

NVRO Solvency Score
Solvency Due Diligence

Nevro Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
42/100
Solvency
Score

Nevro Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NVRO Price Targets Summary
Nevro Corp

Wall Street analysts forecast NVRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVRO is 18.156 USD with a low forecast of 14.14 USD and a high forecast of 42 USD.

Lowest
Price Target
14.14 USD
17% Upside
Average
Price Target
18.156 USD
50% Upside
Highest
Price Target
42 USD
248% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NVRO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NVRO Price
Nevro Corp

1M 1M
-12%
6M 6M
-22%
1Y 1Y
-63%
3Y 3Y
-93%
5Y 5Y
-81%
10Y 10Y
-52%
Annual Price Range
12.0801
52w Low
12.07
52w High
34.59
Price Metrics
Average Annual Return 7.66%
Standard Deviation of Annual Returns 71%
Max Drawdown -93%
Shares Statistics
Market Capitalization 439.3m USD
Shares Outstanding 36 681 400
Percentage of Shares Shorted 19.27%

NVRO Return Decomposition
Main factors of price return

What is price return decomposition?

NVRO News

Other Videos

Company Profile

Nevro Corp Logo
Nevro Corp

Country

United States of America

Industry

Health Care

Market Cap

439.3m USD

Dividend Yield

0%

Description

Nevro Corp. engages in the provision of medical devices. The company is headquartered in Redwood City, California and currently employs 945 full-time employees. The company went IPO on 2014-11-06. The firm has developed and commercialized the Senza spinal cord stimulation (SCS) system. SCS is a neuromodulation platform for the treatment of chronic pain, with the Senza Omnia platform, which is in addition to the Senza family of products. The Company’s solution for chronic pain includes 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain based on what it believes to be the best clinical evidence available. The advantages of its 10 kHz Therapy over traditional SCS include demonstrated superior efficacy data for both leg and back pain, paresthesia free pain relief for patients, anatomical lead placement for physicians, and ability to treat a broader group of chronic pain patients.

Contact

CALIFORNIA
Redwood City
1800 Bridge Pkwy
+16502510005.0
https://www.nevro.com

IPO

2014-11-06

Employees

945

Officers

Senior VP & CFO
Mr. Roderick H. MacLeod
Senior VP, General Counsel & Corporate Secretary
Mr. Kashif Rashid
President, CEO & Director
Mr. Kevin R. Thornal
Chief Accounting Officer
Mr. Richard B. Carter
Senior Vice President of Technical Operations
Mr. Christofer Christoforou
VP and Chief Compliance & Privacy Officer
Geeta Kaveti
Show More
Senior Vice President of Corporate Development
Mr. Jon R. Shear
Vice President of Global Marketing
Meredith Vornholt
Senior VP & Chief of Human Resources Officer
Ms. Shana D. Ross M.B.A.
Senior VP & Chief Medical Officer
Dr. David Caraway M.D., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one NVRO stock?

The intrinsic value of one NVRO stock under the Base Case scenario is 45.7274 USD.

Is NVRO stock undervalued or overvalued?

Compared to the current market price of 12.0801 USD, Nevro Corp is Undervalued by 74%.